Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Opinion Editor's Corner ESC 2025

What’s Going to Be Hot at ESC Congress 2025?

Michael O'Riordan

August 25, 2025

Presentation THT 2025

Mechanistic Observations of How an Atrial Shunt Impacts the Hearts of HFrEF Patients

Presenter: NULL

February 11, 2025

Presentation THT 2024

Update on Baroreceptor Activation Therapy

Presenter: Michael R. Zile

March 05, 2024

Presentation THT 2024

Relationship Between Remote, Ambulatory Pulmonary Artery Pressures and All-Cause Mortality in Patients with Chronic Heart Failure

Presenter: Michael R. Zile

March 05, 2024

Presentation THT 2024

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

Presenter: Michael R. Zile

March 04, 2024

Presentation THT 2023

BeAT-HF: Long-term Safety and Outcomes

Presenter: Michael Zile

March 21, 2023

Presentation THT 2023

Baroreflex Activation Therapy (BAT) in Patients With Heart Failure and a Reduced Ejection Fraction (BeAT-HF): Long-Term Outcomes

Presenter: Michael Zile

March 21, 2023

Presentation THT 2023

Intravascular Monitoring: RA, PA, LA vs LV

Presenter: Michael Zile

March 21, 2023

Presentation TCT 2022

Invasive and Noninvasive Monitoring to Reduce Heart Failure Admissions

Presenter: Michael R. Zile

September 17, 2022

Presentation THT 2022

CVRx - Barostimulation

Presenter: Michael R. Zile

February 02, 2022

News Conference News TCT 2021

GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF

Michael O'Riordan

November 06, 2021

Presentation TCT 2021

GUIDE-HF: A Randomized Trial of Hemodynamic-Guided Management of Heart Failure – Outcomes According to Ejection Fraction

Presenter: Michael Zile

November 06, 2021

Presentation TCT 2021

CVRx - Barostimulation -- CVRx and LivaNova

Presenter: Michael R. Zile

November 06, 2021

News Conference News HRS 2019

BeAT-HF: Baroreflex Activation Therapy Improves Outcomes in Subset of HF Patients

Todd Neale

May 15, 2019

News Industry News

CVRx® Announces that the First Two Patients were Treated in the Phase III Pivotal Trial Evaluating BAROSTIM THERAPY® for the Treatment of Heart Failure

June 06, 2016

News Industry News

CVRx® Barostim Therapy® for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference

May 26, 2015

News Daily News

Renal Denervation Bonus: Improving LV Function

March 05, 2012

News Daily News

El Valor Añadido de la Denervación Renal: Mejora la Función del VI

March 05, 2012

Partner Content

Baroreflex Activation Therapy for HFrEF Patients: New Insights from the BeAT-HF Study

March 29, 2023

Video

» Topical Discussion

Baroreflex Activation Therapy for HFrEF Patients- New Insights from the BeAT-HF Study

March 28, 2023

Advertisement

What’s Going to Be Hot at ESC Congress 2025?

Mechanistic Observations of How an Atrial Shunt Impacts the Hearts of HFrEF Patients

Update on Baroreceptor Activation Therapy

Relationship Between Remote, Ambulatory Pulmonary Artery Pressures and All-Cause Mortality in Patients with Chronic Heart Failure

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

BeAT-HF: Long-term Safety and Outcomes

Baroreflex Activation Therapy (BAT) in Patients With Heart Failure and a Reduced Ejection Fraction (BeAT-HF): Long-Term Outcomes

Intravascular Monitoring: RA, PA, LA vs LV

Invasive and Noninvasive Monitoring to Reduce Heart Failure Admissions

CVRx - Barostimulation

GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF

GUIDE-HF: A Randomized Trial of Hemodynamic-Guided Management of Heart Failure – Outcomes According to Ejection Fraction

CVRx - Barostimulation -- CVRx and LivaNova

BeAT-HF: Baroreflex Activation Therapy Improves Outcomes in Subset of HF Patients

CVRx® Announces that the First Two Patients were Treated in the Phase III Pivotal Trial Evaluating BAROSTIM THERAPY® for the Treatment of Heart Failure

CVRx® Barostim Therapy® for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference

Renal Denervation Bonus: Improving LV Function

El Valor Añadido de la Denervación Renal: Mejora la Función del VI

Baroreflex Activation Therapy for HFrEF Patients: New Insights from the BeAT-HF Study

Baroreflex Activation Therapy for HFrEF Patients- New Insights from the BeAT-HF Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content